Creating models of melanoma brain tumors to improve immune therapy
Official title: Development of immunocompetent melanoma brain metastases organoids
Funded at Univ of Arkansas for Med Scis · NIH-11051251 · Data updated 2026-11-12
This study is creating tiny models of brain tumors from melanoma patients to see how immune cells work in these tumors and to try out new treatments that could help improve care for people with melanoma that has spread to the brain.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Arkansas for Med Scis NIH-funded |
| Lab location | 1 site (Little Rock, United States) |
| Project start | March 6, 2024 |
| Project end | February 28, 2026 |
| Funding year | 2025 |
| Award (this year) | $76,500 |
| NIH project number | 5R03CA289645-02 |
| Project ID | NIH-11051251 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients diagnosed with melanoma that has metastasized to the brain.
✕Less likely to help
Patients with melanoma that has not spread to the brain or those with other types of cancer may not benefit from this research.
What this research studies
This research focuses on developing patient-derived organoid models that replicate the immune environment of melanoma brain metastases. By using these organoids, researchers aim to better understand how immune cells interact within the brain tumors and to test new immune therapies. The approach involves analyzing the cellular communication and immune responses in these models, which could lead to more effective treatments for patients with melanoma that has spread to the brain.
Why it matters
Potential benefit: If successful, this research could lead to improved immune therapies for patients with melanoma brain metastases, potentially enhancing treatment outcomes.
How similar studies have gone: Other research has shown promise in using organoid models for studying cancer, indicating that this approach could be effective.
Where this research is happening
-
Univ of Arkansas for Med Scis
Little Rock, United States Active
Researchers
- Principal investigator: Rodriguez, Analiz — Univ of Arkansas for Med Scis
- Study coordinator: Rodriguez, Analiz
Related research
Other NIH-funded projects on the same topics.
-
Melanoma vaccine built from tiny spherical nucleic acids
A new kind of cancer vaccine using tiny spherical nucleic acids to help the immune system fight advanced melanoma.
-
Injecting immune-boosting medicine into melanoma tumors to help the immune system reject them
This gives an immune-boosting drug directly into melanoma tumors in pet dogs to help their T cells find and destroy the cancer.
-
Understanding and interrupting brain metastasis in cancer patients
A national research effort at Stanford aims to understand why cancer spreads to the brain and to develop ways to interrupt it, with the goal of improving survival and quality of life for people with cancer.
-
SIRT6 and melanoma growth and spread
Researchers are seeing if blocking a protein called SIRT6 can help stop melanoma from growing and spreading in people with melanoma.
-
How tumor cell stress and nearby support cells help melanoma spread
This project looks at whether blocking a tumor cell stress response and changing how nearby support cells behave might keep melanoma cells from surviving, spreading, and resisting treatment.
-
PLK4 as a potential drug target in melanoma
Researchers are exploring whether blocking PLK4 could be a new way to treat melanoma and how PLK4 works with other melanoma-driving pathways.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.